These final results, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the principle of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. In combination with the https://joanr950gnt2.blogofchange.com/profile